In rare instances, South Africa variant may evade Pfizer vaccine, researchers say
(NEW YORK) -- The first real-world study pitting COVID-19 variants against the Pfizer vaccine showed that the variant first detected in South Africa may be able to evade some vaccine protection, new research conducted in Israel found.While "breakthrough" COVID-19 cases, meaning people who get... Read More.
